Literature DB >> 16459884

Complex oral manifestations of an HIV-seropositive patient.

Liviu Feller1, Neil H Wood, Erich Raubenheimer.   

Abstract

A complex manifestation of characteristic oral lesions occurring simultaneously in an HIV-seropositive patient is presented. Necrotizing ulcerative gingivitis (NUG), necrotizing ulcerative periodontitis (NUP), oral-facial herpes infection, pseudomembranous candidiasis and atypical oral ulceration are discussed. In spite of extremely low CD4+ T-cell counts of 3 x 10(6)/L and lack of anti-retroviral therapy, an AIDS patient responded favourably to standard periodontal therapy. In the follow-up period of 3 months, no recurrence of any of the oral lesions initially present occurred and no special prophylactic regimes were needed to maintain oral health. This case illustrates that appropriate management of the oral manifestations contributes significantly to improvement of the quality of life of patients in the terminal stage of HIV-AIDS.

Entities:  

Mesh:

Year:  2006        PMID: 16459884

Source DB:  PubMed          Journal:  J Int Acad Periodontol        ISSN: 1466-2094


  4 in total

1.  Noma (cancrum oris): a report of a case in a young AIDS patient with a review of the pathogenesis.

Authors:  J N Masipa; A M Baloyi; R A G Khammissa; M Altini; J Lemmer; L Feller
Journal:  Head Neck Pathol       Date:  2012-08-21

2.  A Comparison of Chronic Periodontitis in HIV-Seropositive Subjects and the General Population in the Ga-Rankuwa Area, South Africa.

Authors:  Razia Khammissa; Liviu Feller; Mario Altini; Paul Fatti; Johan Lemmer
Journal:  AIDS Res Treat       Date:  2012-08-29

3.  Osteonecrosis of the jaw in an AIDS patient: a case report.

Authors:  Yusuke Zushi; Kazuma Noguchi; Kuniyasu Moridera; Kazuki Takaoka; Hiromitsu Kishimoto
Journal:  AIDS Res Ther       Date:  2015-04-30       Impact factor: 2.250

Review 4.  Noma (cancrum oris): An unresolved global challenge.

Authors:  Liviu Feller; Razia A G Khammissa; Mario Altini; Johan Lemmer
Journal:  Periodontol 2000       Date:  2019-06       Impact factor: 7.589

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.